Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus.
Jeon SH, Ben-Yedidia T, Arnon R. Jeon SH, et al. Vaccine. 2002 Jun 21;20(21-22):2772-80. doi: 10.1016/s0264-410x(02)00187-1. Vaccine. 2002. PMID: 12034104
A universal epitope-based influenza vaccine and its efficacy against H5N1.
Adar Y, Singer Y, Levi R, Tzehoval E, Perk S, Banet-Noach C, Nagar S, Arnon R, Ben-Yedidia T. Adar Y, et al. Among authors: ben yedidia t. Vaccine. 2009 Mar 26;27(15):2099-107. doi: 10.1016/j.vaccine.2009.02.011. Epub 2009 Feb 13. Vaccine. 2009. PMID: 19356612
Peptide-based synthetic recombinant vaccines with anti-viral efficacy.
Arnon R, Tarrab-Hazdai R, Ben-Yedidia T. Arnon R, et al. Biologicals. 2001 Sep-Dec;29(3-4):237-42. doi: 10.1006/biol.2001.0303. Biologicals. 2001. PMID: 11851322
Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.
Ben-Yedidia T, Tarrab-Hazdai R, Schechtman D, Arnon R. Ben-Yedidia T, et al. Infect Immun. 1999 Sep;67(9):4360-6. doi: 10.1128/IAI.67.9.4360-4366.1999. Infect Immun. 1999. PMID: 10456875 Free PMC article.
Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection.
Ben-Yedidia T, Marcus H, Reisner Y, Arnon R. Ben-Yedidia T, et al. Int Immunol. 1999 Jul;11(7):1043-51. doi: 10.1093/intimm/11.7.1043. Int Immunol. 1999. PMID: 10383936
Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine.
Ben-Yedidia T, Arnon R. Ben-Yedidia T, et al. Immunol Lett. 1998 Nov;64(1):9-15. doi: 10.1016/s0165-2478(98)00073-x. Immunol Lett. 1998. PMID: 9865596
Design of peptide and polypeptide vaccines.
Ben-Yedidia T, Arnon R. Ben-Yedidia T, et al. Curr Opin Biotechnol. 1997 Aug;8(4):442-8. doi: 10.1016/s0958-1669(97)80066-3. Curr Opin Biotechnol. 1997. PMID: 9265723 Review.
Efficacy of anti-influenza peptide vaccine in aged mice.
Ben-Yedidia T, Abel L, Arnon R, Globerson A. Ben-Yedidia T, et al. Mech Ageing Dev. 1998 Aug 1;104(1):11-23. doi: 10.1016/s0047-6374(98)00045-1. Mech Ageing Dev. 1998. PMID: 9751429
A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization.
Ben-Yedidia T, Beignon AS, Partidos CD, Muller S, Arnon R. Ben-Yedidia T, et al. Mol Immunol. 2002 Oct;39(5-6):323-31. doi: 10.1016/s0161-5890(02)00095-0. Mol Immunol. 2002. PMID: 12220890
Flagella as a platform for epitope-based vaccines.
Ben-Yedidia T, Arnon R. Ben-Yedidia T, et al. Isr Med Assoc J. 2006 May;8(5):316-8. Isr Med Assoc J. 2006. PMID: 16805228 No abstract available.
25 results
Jump to page